Balance Sheet

Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Growth Metrics

Medicure (MCUJF) Change in Acquisitions & Divestments (2018 - 2019)

Medicure has reported Change in Acquisitions & Divestments over the past 2 years, most recently at $34.0 million for Q2 2019.

For Q2 2019, Change in Acquisitions & Divestments rose 543.69% year-over-year to $34.0 million; the TTM value through Dec 2019 reached $35.7 million, up 201.38%, while the annual FY2019 figure was $36.2 million, 206.21% up from the prior year.
Change in Acquisitions & Divestments for Q2 2019 was $34.0 million at Medicure, up from $1.7 million in the prior quarter.
Over five years, Change in Acquisitions & Divestments peaked at $34.0 million in Q2 2019 and troughed at -$44.9 million in Q1 2018.